Thomas Leggett - May 15, 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Chief Financial Officer
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
May 15, 2024
Transactions value $
$0
Form type
4
Date filed
5/17/2024, 04:14 PM
Previous filing
May 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Stock Option (Right to Buy) Award $0 +396K $0.00 396K May 15, 2024 Common Stock 396K $14.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/4 of the total award on May 7, 2025, and as to 1/48 of the total award monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date.